CASSANDRA KEADY: Open Payments
NPI 1912612193 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 9 payments from 8 companies in 2025. Trend: 2023 $431 · 2024 $432 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 2 | $53 |
| JAZZ PHARMACEUTICALS INC. | 1 | $39 |
| ConvaTec Inc. | 1 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| ABBVIE INC. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| AngioDynamics, Inc. | 1 | $23 |
Products named: Lenvima, ZEPZELCA, AQUACEL AG+ EXTRA, Vitrakvi, LYNPARZA, CREON, LUTATHERA, SMART PORT CT.
Industry payments across MD — which companies pay providers there.
